Takeda Pharmaceutical Co. Ltd sales and marketing update

Takeda launched Zacras azilsartan/amlodipine besylate in Japan to treat hypertension. The once-daily, fixed-dose combination of azilsartan and amlodipine besylate has a Japanese National Health Insur...